← Leaderboards
Milan Girish Chheda
Washington University
$4,663,006
Attributed
$4,663,006
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $737.2K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,663,006 · 3
By mechanism
R01$3,773,453 · 2
K08$889,553 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Fred M Ssewamala$23,799,753
- Proscovia Nabunya$3,258,575
- Harrison W Gabel$7,060,288
- Ozge Sensoy Bahar$3,487,653
- Massy Mutumba$1,986,629
Others in their field
Top investigators on “Glioblastoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$50,454,235
- John H Sampson · Duke University$34,869,540
- Walter John Curran · Thomas Jefferson University$27,327,059
- Jann N Sarkaria · Mayo Clinic Coll Of Medicine, Rochester$23,947,143
- Jeremy N Rich · University Of Pittsburgh At Pittsburgh$21,935,828
- Maciej S Lesniak · Northwestern University$18,837,339
Research focus
GlioblastomaCellsGeneticTumorMediatingIn VivoPublic HealthStem CellsCessation Of LifeBrain NeoplasmsRecruitDeteriorationPropertyNeurologicResistanceTemozolomideExperimental StudyNeoplastic CellPlayAggressive TherapyPrimary Brain NeoplasmsCell LineMaintenanceIn Vitro
Grant awards (16)
Leveraging Zika virus and the immune system to treat glioblastoma$401,786
R01 · FY2025 · NS · contact PI
Leveraging Zika virus and the immune system to treat glioblastoma$418,485
R01 · FY2024 · NS · contact PI
Leveraging Zika virus and the immune system to treat glioblastoma$456,534
R01 · FY2023 · NS · contact PI
Leveraging Zika virus and the immune system to treat glioblastoma$392,641
R01 · FY2022 · NS · contact PI
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state$344,531
R01 · FY2022 · NS · contact PI
Leveraging Zika virus and the immune system to treat glioblastoma$389,854
R01 · FY2021 · NS · contact PI
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state$344,531
R01 · FY2021 · NS · contact PI
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state$344,441
R01 · FY2020 · NS · contact PI
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state$343,164
R01 · FY2019 · NS · contact PI
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state$337,486
R01 · FY2018 · NS · contact PI
Characterization of GEFT AS a Novel Glioblastoma Oncogene$185,690
K08 · FY2014 · NS · contact PI
Characterization of GEFT AS a Novel Glioblastoma Oncogene$184,610
K08 · FY2013 · NS · contact PI
Characterization of GEFT AS a Novel Glioblastoma Oncogene$170,861
K08 · FY2012 · NS · contact PI
Characterization of GEFT AS a Novel Glioblastoma Oncogene$170,861
K08 · FY2011 · NS · contact PI
Characterization of GEFT AS a Novel Glioblastoma Oncogene$115,566
K08 · FY2009 · NS · contact PI
Characterization of GEFT AS a Novel Glioblastoma Oncogene$61,965
K08 · FY2009 · NS · contact PI